from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0187/-

LFCtreatmentdescriptionclass of inhibitor

-0.694

Amikacinug/mL Amikacintranslation

-0.550

Cap5-10ug/mL Capreomycintranslation

-1.277

Rox10-50 ug/mL Roxithromycintranslation

0.080

SM2-5 ug/mL Streptomycintranslation

-0.615

Tet5-10 ug/mL Tetracyclinetranslation

0.895

Rif0.2-5ug/mL Rifampicintranscription

-0.768

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.982

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.000

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.583

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.336

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.153

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.456

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.608

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.637

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.330

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.113

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.162

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.282

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.067

KCN5-20 ug/mL Potassium cyaniderespiration

-1.961

NaN30.2-2 mM Sodium aziderespiration

-1.148

Nigericin50 uM Nigericinrespiration

0.275

TRC10-150 ug/mL Triclosanrespiration

-0.796

TRZ10-25 ug/mL Thioridazinerespiration

-0.816

Valinomycin0.5-10 uM Valinomycinrespiration

-1.030

ZnSO42 mM ZnSO4respiration

-1.077

menadione6-10 ug/mL Menadionerespiration

-0.774

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.117

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.118

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.905

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.483

NRP_1Non-replicating persistence stage 1dosRassociated

0.441

Amp0.2mg/mL AmpicillincellWall

0.277

Cephalexin20-100 ug/mL CephalexincellWall

-0.182

Cerulenin0.32-5 ug/mL CerulenincellWall

1.165

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.496

EMB10-20 ug/mL EthambutolcellWall

0.265

Eta12-40 ug/mL EthionamidecellWall

0.612

INH0.2-0.4 ug/mL IsoniazidcellWall

0.126

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.433

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.555

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.463

BZA0.12 mg/mL BenzamidearomaticAmides

0.133

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.239

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.599

H2O24 mM hydrogen peroxideDNAdamaging

-0.644

Levo10 ug/mL LevofloxacinDNAdamaging

0.422

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.886

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.730

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.538

UVUV-irradiationDNAdamaging

-0.394

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.480

Antimycin12.5-50 ug/mL Antimycin A?

-0.332

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.413

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.142

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.369

PA8240.2-2 ug/mL PA-824?

0.076

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.102

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.787

Verapamil50 uM Verapamil?

-0.238

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.539

methoxatin10-20 ug/mL Methoxatin?